Processa Pharmaceuticals, Inc. (PCSA) vs WORK Medical Technology Group Ltd. Class A (WOK)
A side-by-side comparison of Processa Pharmaceuticals, Inc. and WORK Medical Technology Group Ltd. Class A across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PCSA
Processa Pharmaceuticals, Inc.
$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WOK
WORK Medical Technology Group Ltd. Class A
$1.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PCSA vs WOK
growth of $100 · dividends reinvested · last 2yPCSA -96.1% (-80.3%/yr)WOK -100.0% (-99.9%/yr)PCSA compounded faster over this window
Log scale — wide-divergence pair
PCSA WOK
PCSA vs WOK: by the numbers
- •PCSA is the larger company ($4M vs $4M market cap).
- •Both run net losses; PCSA's is the smaller (0.00% vs -10.89% net margin).
Metrics side by side
Valuation
| Metric | PCSA | WOK |
|---|---|---|
| P/B ratio | N/A | 0.12 |
Profitability
| Metric | PCSA | WOK |
|---|---|---|
| Gross margin | 0.00% | 23.81% |
| Operating margin | 0.00% | -25.34% |
| Net margin | 0.00% | -10.89% |
| ROE | N/A | -5.85% |
| ROIC | N/A | -9.04% |
Growth (annualized)
| Metric | PCSA | WOK |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -28.44% |
| Total return CAGR (5Y) | -79.32% | N/A |
Go deeper
Dig into the metrics
Processa Pharmaceuticals ROEWORK Medical Technology Group ROEProcessa Pharmaceuticals operating marginWORK Medical Technology Group operating marginProcessa Pharmaceuticals revenue growthWORK Medical Technology Group revenue growthProcessa Pharmaceuticals free cash flowWORK Medical Technology Group free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.